Prior treatment with vitamin K2 significantly improves the efficacy of risedronate

Osteoporosis International

Volumn 20, Issue 11, 2009, Pages 1863-1872

  Matsumoto, Y ^a   Mikuni Takagaki, Y ^a   Kozai, Y ^a   Miyagawa, K ^a,c   Naruse, K ^b   Wakao, H ^a   Kawamata, R ^a   Kashima, I ^a   Sakurai, T ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Bisphosphonate; Quality of bone; Raman spectroscopy; Risedronate; Sequential administration; Vitamin K2

Indexed keywords

FARNOQUINONE; MK 4; RISEDRONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE STRENGTH; BONE STRUCTURE; COMPRESSIVE STRENGTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFICACY; FEMALE; FEMUR; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; TRABECULAR BONE; TREATMENT DURATION;

ANIMALS; BODY WEIGHT; BONE DENSITY CONSERVATION AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; FEMUR; MICE; MICE, INBRED ICR; OSTEOPOROSIS; OVARIECTOMY; VITAMIN K 2;

EID: 76449090333     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0888-z     Document Type: Article

References (40)

1. PD Delmas P Vergnaud ME Arlot P Pastoureau PJ Meunier MH Nilssen 1995 The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16 6 603 610 10.1016/8756-3282(95)00113-R 7669436 1:CAS:528:DyaK2MXmsVKjurs%3D
2. RW Boyce CL Paddock AF Franks ML Jankowsky EF Eriksen 1996 Effects of intermittent hPTH(1-34) alone and in combination with 1, 25(OH)(2) D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone J Bone Miner Res 11 5 600 613 9157775 1:CAS:528:DyaK28XjtVGksrs%3D
3. DM Black JP Bilezikian KE Ensrud SL Greenspan L Palermo T Hue TF Lang JA McGowan CJ Rosen 2005 One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis N Engl J Med 353 6 555 565 10.1056/NEJMoa050336 16093464 1:CAS:528:DC%2BD2MXnsVWmtb0%3D (Pubitemid 41138937)
4. T Masud B Mulcahy AV Thompson S Donnelly RW Keen DV Doyle TD Spector 1998 Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women Ann Rheum Dis 57 6 346 349 10.1136/ard.57.6.346 9771208 1:CAS:528:DyaK1cXls1ejsrc%3D
5. SJ Wimalawansa 1998 A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis Am J Med 104 3 219 226 10.1016/S0002-9343(98)00029-1 9552083 1:CAS:528:DyaK1cXislKhsLk%3D (Pubitemid 28163165)
6. R Lindsay F Cosman RA Lobo BW Walsh ST Harris JE Reagan CL Liss ME Melton CA Byrnes 1999 Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial J Clin Endocrinol Metab 84 9 3076 3081 10.1210/jc.84.9.3076 10487668 1:CAS:528:DyaK1MXlvVGks7g%3D
7. SL Greenspan NM Resnick RA Parker 2003 Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial JAMA 289 19 2525 2533 10.1001/jama.289.19.2525 12759324 1:CAS:528:DC%2BD3sXjvFCkurg%3D (Pubitemid 37430154)
8. L Stabnov Y Kasukawa R Guo Y Amaar JE Wergedal DJ Baylink S Mohan 2002 Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice Bone 30 6 909 916 10.1016/S8756-3282(02)00738-X 12052462 1:CAS:528:DC%2BD38XktFynt7s%3D (Pubitemid 34616022)
9. NB Watts 2003 Bisphosphonate treatment of osteoporosis Clin Geriatr Med 19 2 395 414 10.1016/S0749-0690(02)00069-1 12916293 (Pubitemid 36514526)
10. M Shiraki Y Shiraki C Aoki M Miura 2000 Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis J Bone Miner Res 15 3 515 521 10.1359/jbmr.2000.15.3.515 10750566 1:CAS:528:DC%2BD3cXitFaktrc%3D
11. M Kaneki SJ Hodges T Hosoi S Fujiwara A Lyons SJ Crean N Ishida M Nakagawa M Takechi Y Sano Y Mizuno S Hoshino M Miyao S Inoue K Horiki M Shiraki Y Ouchi H Orimo 2001 Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk Nutrition 17 4 315 321 10.1016/S0899-9007(00) 00554-2 11369171 1:CAS:528:DC%2BD3MXjtlChtro%3D (Pubitemid 32454984)
12. K Hara M Kobayashi Y Akiyama 2002 Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats Bone 31 5 575 581 10.1016/S8756-3282(02)00874-8 12477571 1:CAS:528:DC%2BD38XptlGisr8%3D (Pubitemid 35449699)
13. K Hara Y Akiyama T Nakamura S Murota I Morita 1995 The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain Bone 16 2 179 184 10.1016/8756-3282(94)00027-W 7756045 1:CAS:528:DyaK2MXltlCrtLg%3D
14. M Igarashi Y Yogiashi M Mihara I Takada H Kitagawa S Kato 2007 Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene Mol Cell Biol 27 22 7947 7954 10.1128/MCB.00813-07 17875939 1:CAS:528:DC%2BD2sXhtlWmsrjO (Pubitemid 350086427)
15. Y Iwasaki H Yamato H Murayama M Sato T Takahashi I Ezawa K Kurokawa M Fukagawa 2003 Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats J Bone Miner Metab 21 3 154 160 10.1007/s007740300024 12720049 1:CAS:528:DC%2BD3sXjt1Gju74%3D (Pubitemid 41184296)
16. J Iwamoto T Takeda Y Sato CL Shen JK Yeh 2006 Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study5 J Nutr Sci Vitaminol (Tokyo) 52 5 307 315 10.3177/jnsv.52.307 1:CAS:528:DC%2BD28Xht1ejtbjL (Pubitemid 46065546)
17. N Binkley D Krueger J Engelke T Crenshaw J Suttie 2002 Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats Bone 30 6 897 900 10.1016/S8756-3282(02)00734-2 12052460 1:CAS:528:DC%2BD38XktFynt70%3D (Pubitemid 34616020)
18. H Otomo A Sakai S Ikeda S Tanaka M Ito RJ Phipps T Nakamura 2004 Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2 J Bone Miner Metab 22 5 404 414 10.1007/s00774-004-0502-6 15316861 1:CAS:528:DC%2BD2cXmslCitLc%3D (Pubitemid 39248835)
19. L Pothuaud E Lespessailles R Harba R Jennane V Royant E Eynard CL Benhamou 1998 Fractal analysis of trabecular bone texture on radiographs: discriminant value in postmenopausal osteoporosis6 Osteoporos Int 8 6 618 625 10.1007/s001980050108 10326070 1:STN:280:DyaK1M3lsl2hsg%3D%3D (Pubitemid 28566980)
20. A Laib JL Kumer S Majumdar NE Lane 2001 The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT Osteoporos Int 12 11 936 941 10.1007/s001980170022 11804020 1:STN:280: DC%2BD38%2FnvVWmsQ%3D%3D (Pubitemid 34001007)
21. PM Lind L Lind S Larsson J Orberg 2001 Torsional testing and peripheral quantitative computed tomography in rat humerus Bone 29 3 265 270 10.1016/S8756-3282(01)00576-2 11557371 1:STN:280:DC%2BD3MrgvFyguw%3D%3D (Pubitemid 32823570)
22. CP Tarnowski MA Ignelzi Jr. W Wang JM Taboas SA Goldstein MD Morris 2004 Earliest mineral and matrix changes in force-induced musculoskeletal disease as revealed by Raman microspectroscopic imaging J Bone Miner Res 19 1 64 71 10.1359/JBMR.0301201 14753738 (Pubitemid 41295139)
23. JS Yerramshetty O Akkus 2008 The associations between mineral crystallinity and the mechanical properties of human cortical bone Bone 42 3 476 482 10.1016/j.bone.2007.12.001 18187375 1:CAS:528:DC%2BD1cXitVOmtbY%3D
24. SJ Hodges K Akesson P Vergnaud K Obrant PD Delmas 1993 Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture J Bone Miner Res 8 10 1241 1245 8256661 1:STN:280:DyaK2c%2FnvVyhtw%3D%3D
25. T Kanai T Takagi K Masuhiro M Nakamura M Iwata F Saji 1997 Serum vitamin K level and bone mineral density in post-menopausal women Int J Gynaecol Obstet 56 1 25 30 10.1016/S0020-7292(96)02790-7 9049691 1:CAS:528:DyaK2sXhs1Omtrs%3D (Pubitemid 27067761)
26. H Luukinen SM Kakonen K Pettersson K Koski P Laippala T Lovgren SL Kivela HK Vaananen 2000 Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin J Bone Miner Res 15 12 2473 2478 10.1359/jbmr.2000.15.12.2473 11127212 1:CAS:528:DC%2BD3cXovVShsL0%3D
27. P Vergnaud P Garnero PJ Meunier G Breart K Kamihagi PD Delmas 1997 Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study J Clin Endocrinol Metab 82 3 719 724 10.1210/jc.82.3.719 9062471 1:CAS:528:DyaK2sXhsl2jsL4%3D (Pubitemid 27106576)
28. SL Booth KL Tucker H Chen MT Hannan DR Gagnon LA Cupples PW Wilson J Ordovas EJ Schaefer B wson-Hughes DP Kiel 2000 Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women Am J Clin Nutr 71 5 1201 1208 10799384 1:CAS:528:DC%2BD3cXivFymsbs%3D
29. D Feskanich P Weber WC Willett H Rockett SL Booth GA Colditz 1999 Vitamin K intake and hip fractures in women: a prospective study Am J Clin Nutr 69 1 74 79 9925126 1:CAS:528:DyaK1MXjvFSmtA%3D%3D
30. M Hirao J Hashimoto W Ando T Ono H Yoshikawa 2008 Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women J Bone Miner Metab 26 3 260 264 10.1007/s00774-007-0823-3 18470667 1:CAS:528:DC%2BD1cXls1Kntr4%3D (Pubitemid 351677843)
31. Y Akiyama K Hara I Ohkawa T Tajima 1993 Effects of menatetrenone on bone loss induced by ovariectomy in rats Jpn J Pharmacol 62 2 145 153 10.1254/jjp.62.145 8371513 1:CAS:528:DyaK3sXkvVKjs74%3D (Pubitemid 23218233)
32. T Mawatari H Miura H Higaki T Moro-Oka K Kurata T Murakami Y Iwamoto 2000 Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats J Bone Miner Res 15 9 1810 1817 10.1359/jbmr.2000.15.9.1810 10977000 1:CAS:528:DC%2BD3cXmsF2mtLg%3D
33. A Shiraishi S Higashi T Masaki M Saito M Ito S Ikeda T Nakamura 2002 A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis Calcif Tissue Int 71 1 69 79 10.1007/s00223-001-2090-y 12073154 1:CAS:528:DC%2BD38Xms12gtbg%3D (Pubitemid 36934779)
34. N Binkley D Krueger J Engelke J Suttie 2007 Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys J Bone Miner Res 22 5 695 700 10.1359/jbmr.070208 17295605 1:CAS:528:DC%2BD2sXpt1yrt7g%3D (Pubitemid 351339097)
35. PA Price 1985 Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function Vitam Horm 42 65 108 10.1016/S0083-6729(08)60061- 8 3006348 1:CAS:528:DyaL28Xht1Ojsbc%3D
36. Y Koshihara K Hoshi H Ishibashi M Shiraki 1996 Vitamin K2 promotes 1alpha, 25(OH) 2 vitamin D3-induced mineralization in human periosteal osteoblasts Calcif Tissue Int 59 6 466 473 8939773 1:CAS:528:DyaK28XnsVWit7w%3D
37. P Ducy C Desbois B Boyce G Pinero B Story C Dunstan E Smith J Bonadio S Goldstein C Gundberg A Bradley G Karsenty 1996 Increased bone formation in osteocalcin-deficient mice Nature 382 6590 448 452 10.1038/382448a0 8684484 1:CAS:528:DyaK28Xks1Olur0%3D (Pubitemid 26264860)
38. T Ichikawa K Horie-Inoue K Ikeda B Blumberg S Inoue 2006 Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells J Biol Chem 281 25 16927 16934 10.1074/jbc.M600896200 16606623 1:CAS:528:DC%2BD28XlvVGksrY%3D (Pubitemid 43909495)
39. SK Lim YJ Won HC Lee KB Huh YS Park 1999 A PCR analysis of ERalpha and ERbeta mRNA abundance in rats and the effect of ovariectomy J Bone Miner Res 14 7 1189 1196 10.1359/jbmr.1999.14.7.1189 10404020 1:CAS:528:DyaK1MXkvVyjsbw%3D (Pubitemid 29314063)
40. FA Syed UI Modder DG Fraser TC Spelsberg CJ Rosen A Krust P Chambon JL Jameson S Khosla 2005 Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways J Bone Miner Res 20 11 1992 2001 10.1359/JBMR.050713 16234973 1:CAS:528:DC%2BD2MXht1amt7bM (Pubitemid 41532785)